Beta Agonist Feed Additives Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 2.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Beta Agonist Feed Additives Market Analysis
The Global Beta Agonist Feed Additive Market is projected to grow at a CAGR of 2.8% during the forecast period (2020-2025). North America to dominate the beta-agonist feed additive market by garnering nearly 77% of the global sales in 2018. According to the US Department of Agriculture (USDA), the year 2018 set a record of 222.2 pounds per capita of animal meat being consumed in the United States, breaking the previous year's record of 216.9 pounds per capita. The growing consumption of meat is expected to stimulate the production of cattle, which in turn, may bolster the US beta-agonist feed additives market in the forecast period. 60-80% of the US fed cattle are raised with a beta-agonist, like Optaflexx (ractopamine hydrochloride) sold by Elanco Animal Health or Zilmax (zilpaterol hydrochloride) manufactured by Merck Animal Health. The increasing demand for animal meat, including ruminant and swine meat around the world, and the health benefits of beta-agonist feed additives are some of the major driving factors for the global beta-agonist feed additive market.
Beta Agonist Feed Additives Market Trends
This section covers the major market trends shaping the Beta Agonist Feed Additives Market according to our research experts:
Increasing Demand for Animal Meat to Boost the Beta Agonist Feed Additive Sales
There has been increasing pressure on the livestock industry, to meet the increasing demand for meat and high-value animal protein. Population growth, rising incomes in developing nations, and urbanization have led to a surge in global livestock production. The level of income and consumption of animal protein is directly related to the consumption of milk, meat, and eggs, which are increasing at the expense of staple foods. Due to a decline in the prices of meat and meat products, developing countries are beginning to consume large quantities of meat, at a much lower level of the gross domestic product than industrialized countries did, two to three decades back. Urbanization has led to increased demand for meat and milk products in cities when compared to the rural areas.
The global meat market has maintained its growth, and the global consumption of meat products is expected to witness a significant CAGR over the forecast period. The highest growth in meat consumption is expected from the Asia-Pacific and Latin American regions, because of changing diet patterns, urbanization, population, and economic growth. For example, Chinese demand for meat continues to surpass the domestic supply, according to Agriculture and Agri-food Canada.
United States to Dominate the Beta Agonist Feed Additive Sales
The United States Market is projected to grow at a CAGR of 3.8% during the forecast period (2020-2025). Meat, particularly beef, is the centerpiece of the average American dinner. According to the US Department of Agriculture (USDA), the year 2018 set a record of 222.2 pounds per capita of animal meat being consumed in the United States, breaking the previous year's record of 216.9 pounds per capita.
The growing consumption of meat is expected to stimulate the production of cattle, which in turn, may bolster the US beta-agonist feed additives market in the forecast period. 60-80% of the US fed cattle are raised with a beta-agonist, like Optaflexx (ractopamine hydrochloride) sold by Elanco Animal Health or Zilmax (zilpaterol hydrochloride) manufactured by Merck Animal Health. However, in 2013, Merck Animal Health had halted the production of Zilmax, following which Tyson Foods, one of the largest processors of meat, also stopped purchasing the drug. The result of lesser production and usage of Zilmax has left a negative influence on the market. Since the time Zilmax was banned, Optaflexx has been performing well in the US market, accounting for the majority share of the beta-agonist feed additives market.
Beta Agonist Feed Additives Industry Overview
There are very few players, who offer beta-agonist feed additives, as most players in the market offer the same products and innovations, in terms of new products, and are anticipated to give a competitive advantage, thereby resulting in a very concentrated competitive spacing in the global beta-agonist feed additives market.
Beta Agonist Feed Additives Market Leaders
Merck Animal Health
Elanco Animal Health
Zoetis
Quality Liquid Feeds
Heer Pharma Private Limited
*Disclaimer: Major Players sorted in no particular order
Beta Agonist Feed Additives Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions & Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.3 Market Restraints
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Bargaining Powers of Buyers
-
4.4.2 Bargaining Powers of Suppliers
-
4.4.3 Threat of New Entrants
-
4.4.4 Threat of Substitutes
-
4.4.5 Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 Type
-
5.1.1 Ractopamine
-
5.1.2 Zilpaterol
-
-
5.2 Animal Type
-
5.2.1 Swine
-
5.2.2 Ruminants
-
5.2.3 Others
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
5.3.1.4 Rest of North America
-
-
5.3.2 Asia-Pacific
-
5.3.2.1 Japan
-
5.3.2.2 South Korea
-
5.3.2.3 India
-
5.3.2.4 Rest of Asia-Pacific
-
-
5.3.3 South America
-
5.3.3.1 Brazil
-
5.3.3.2 Argentina
-
5.3.3.3 Rest of South America
-
-
5.3.4 Rest of the World
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Most Adopted Strategies
-
6.2 Market Share Analysis
-
6.3 Company Profiles
-
6.3.1 Merck Animal Health
-
6.3.2 Elanco Animal Health
-
6.3.3 Zoetis
-
6.3.4 Quality Liquid Feeds
-
6.3.5 Heer Pharma Private Limited
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
-
8. IMPACT OF COVID-19
Beta Agonist Feed Additives Industry Segmentation
Beta-agonists feed additives are used to feed ruminants and swine, especially before slaughtering. They are approved feed additives, which help in escalating lean muscle gain, increase growth rate, and feed efficiency. The report presents an in-depth analysis of the market share, size, and trends of the global beta-agonist feed additive market. It comprises a comprehensive analysis of market segmentation on the basis of types of feed additives and animal types for which, feed additives are used.
| Type | |
| Ractopamine | |
| Zilpaterol |
| Animal Type | |
| Swine | |
| Ruminants | |
| Others |
| Geography | ||||||
| ||||||
| ||||||
| ||||||
| Rest of the World |
Beta Agonist Feed Additives Market Research FAQs
What is the current Beta Agonist Feed Additive Market size?
The Beta Agonist Feed Additive Market is projected to register a CAGR of 2.80% during the forecast period (2024-2029)
Who are the key players in Beta Agonist Feed Additive Market?
Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feeds and Heer Pharma Private Limited are the major companies operating in the Beta Agonist Feed Additive Market.
Which is the fastest growing region in Beta Agonist Feed Additive Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Beta Agonist Feed Additive Market?
In 2024, the North America accounts for the largest market share in Beta Agonist Feed Additive Market.
What years does this Beta Agonist Feed Additive Market cover?
The report covers the Beta Agonist Feed Additive Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Beta Agonist Feed Additive Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Beta Agonist Feed Additive Industry Report
Statistics for the 2024 Beta Agonist Feed Additive market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Beta Agonist Feed Additive analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
